CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine

by Roberto S. Accolla, Elise Ramia, Alessandra Tedeschi, Greta Forlani
Published 2019-07-01

Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1

by Greta Forlani, Mariam Shallak, Elise Ramia, Alessandra Tedeschi, Roberto S. Accolla
Published 2019-11-01

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells

by Farah Bou Nasser Eddine, Elise Ramia, Giovanna Tosi, Greta Forlani, Roberto S. Accolla
Published 2017-11-01

CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeuti...

by Elise Ramia, Anna Maria Chiaravalli, Farah Bou Nasser Eddine, Alessandra Tedeschi, Fausto Sessa, Roberto S. Accolla, Greta Forlani
Published 2019-03-01